Research Article
Fetal Fibronectin as a Predictor of Preterm Delivery: A Nigerian Cohort Study
Table 3
Maternal clinical characteristics and drugs administered.
| Variable | Case (n,%) | Control (n,%) | X2 | P-value |
| GA at test | | | 0.58 | 0.75 | >30wks | 10 (10.4) | 7 (7.3) | | | 30-36wks | 67 (69.8) | 69 (71.9) | | | >36wks | 19 (19.8) | 20 (20.8) | | | Vaginal bleeding | | | | | No | 96 (100) | 96 (100) | | | Yes | 0 | 0 | | | Uterine contractions in 10 minutes | | | 192 | 0.001 | Nil | 0 | 96 (100) | | | 1 | 27 (28.1) | 0 | | | 2 | 52 (54.2) | 0 | | | 3 | 15 (15.6) | 0 | | | 4 | 1 (1.04) | 0 | | | 5 | 1 (1.04) | 0 | | | Steroid given | | | 67.6 | 0.001 | No | 46 (47.9) | 96 (100) | | | Yes | 50 (52.08) | 0 | | | Tocolytic given | | | 162.5 | 0.001 | No | 8 (8.3) | 96 (100) | | | Yes | 88 (91.7) | 0 | | |
|
|